Cladribine is a purine nucleoside analog and antimetabolite utilized as a therapeutic agent for hairy cell leukemia, B-cell chronic lymphocytic leukemia, and multiple sclerosis. To ensure safety and regulatory… Read more









Cladribine is a purine nucleoside analog and antimetabolite utilized as a therapeutic agent for hairy cell leukemia, B-cell chronic lymphocytic leukemia, and multiple sclerosis. To ensure safety and regulatory compliance, pharmaceutical laboratories utilize comprehensive reference standards for the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. These materials are fundamental to robust analytical method validation, allowing for precise impurity profiling and the detection of degradation products such as those resulting from hydrolysis or oxidation. Stable isotope-labelled compounds act as vital internal standards in liquid chromatography-mass spectrometry, enabling accurate quantification and characterization during quality control processes. By accessing these characterized standards, researchers can verify the potency, stability, and integrity of the drug throughout its development and manufacturing stages.